ATE477826T1 - Pulverformulierungs-disintegrationssystem und trockenpulverinhalatoren - Google Patents

Pulverformulierungs-disintegrationssystem und trockenpulverinhalatoren

Info

Publication number
ATE477826T1
ATE477826T1 AT02780833T AT02780833T ATE477826T1 AT E477826 T1 ATE477826 T1 AT E477826T1 AT 02780833 T AT02780833 T AT 02780833T AT 02780833 T AT02780833 T AT 02780833T AT E477826 T1 ATE477826 T1 AT E477826T1
Authority
AT
Austria
Prior art keywords
powder
disintegration system
inhalers
dry powder
formulation disintegration
Prior art date
Application number
AT02780833T
Other languages
English (en)
Inventor
Boer Anne De
Henderik FRIJLINK
Doetie GJALTEMA
Joachim Goede
Paul Hagedoorn
Original Assignee
Almirall Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Sa filed Critical Almirall Sa
Application granted granted Critical
Publication of ATE477826T1 publication Critical patent/ATE477826T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0086—Inhalation chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A61M11/002—Particle size control by flow deviation causing inertial separation of transported particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2206/00—Characteristics of a physical parameter; associated device therefor
    • A61M2206/10—Flow characteristics
    • A61M2206/16—Rotating swirling helical flow, e.g. by tangential inflows

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
AT02780833T 2001-06-22 2002-06-15 Pulverformulierungs-disintegrationssystem und trockenpulverinhalatoren ATE477826T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10129703A DE10129703A1 (de) 2001-06-22 2001-06-22 Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren
PCT/EP2002/006610 WO2003000325A1 (en) 2001-06-22 2002-06-15 Powder formulation disintegrating system and method for dry powder

Publications (1)

Publication Number Publication Date
ATE477826T1 true ATE477826T1 (de) 2010-09-15

Family

ID=7688810

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02780833T ATE477826T1 (de) 2001-06-22 2002-06-15 Pulverformulierungs-disintegrationssystem und trockenpulverinhalatoren

Country Status (31)

Country Link
EP (1) EP1397174B1 (de)
JP (1) JP4116537B2 (de)
KR (1) KR100904955B1 (de)
CN (1) CN100337699C (de)
AR (1) AR034616A1 (de)
AT (1) ATE477826T1 (de)
AU (1) AU2009200071B2 (de)
BG (1) BG66589B1 (de)
BR (2) BR0210026A (de)
CA (1) CA2445892C (de)
CY (1) CY1110924T1 (de)
CZ (1) CZ302528B6 (de)
DE (2) DE10129703A1 (de)
DK (1) DK1397174T3 (de)
ES (1) ES2350973T3 (de)
HK (1) HK1064313A1 (de)
HR (1) HRP20040058B1 (de)
HU (1) HU227457B1 (de)
IL (3) IL158614A0 (de)
MX (1) MXPA03011550A (de)
NO (1) NO332992B1 (de)
NZ (1) NZ530308A (de)
PL (1) PL204900B1 (de)
PT (1) PT1397174E (de)
RU (1) RU2291717C2 (de)
SI (1) SI1397174T1 (de)
SK (1) SK288034B6 (de)
TW (1) TW567075B (de)
UA (1) UA74648C2 (de)
WO (1) WO2003000325A1 (de)
ZA (1) ZA200308555B (de)

Families Citing this family (106)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
EP1488819A1 (de) 2003-06-16 2004-12-22 Rijksuniversiteit te Groningen Trockenpulverinhalator und Verfahren zur pulmonalen Inhalation von Trockenpulver
RU2258539C1 (ru) * 2004-03-23 2005-08-20 Чучалин Александр Григорьевич Порошковый ингалятор
ES2265276B1 (es) 2005-05-20 2008-02-01 Laboratorios Almirall S.A. Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.
DE102005046645B3 (de) * 2005-09-29 2006-07-20 Braunform Gmbh Pulverinhalator
DE102005046644B3 (de) * 2005-09-29 2006-07-20 Braunform Gmbh Pulverinhalator
DE102006007495A1 (de) * 2006-02-17 2007-08-23 Siegfried Generics International Ag Dispergiereinheit
EP2004258A1 (de) * 2006-04-13 2008-12-24 Boehringer Ingelheim Microparts Gmbh Abgabevorrichtung
ES2319596B1 (es) 2006-12-22 2010-02-08 Laboratorios Almirall S.A. Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico.
ES2320955B1 (es) 2007-03-02 2010-03-16 Laboratorios Almirall S.A. Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
ES2569359T3 (es) * 2007-07-06 2016-05-10 Vectura Delivery Devices Limited Inhalador
EP2020249A1 (de) 2007-08-01 2009-02-04 Boehringer Ingelheim Pharma GmbH & Co. KG Inhalator
UY31272A1 (es) 2007-08-10 2009-01-30 Almirall Lab Nuevos derivados de ácido azabifenilaminobenzoico
DE102007041720A1 (de) * 2007-09-04 2009-03-05 Alfred Von Schuckmann Vorrichtung zur Darreichung eines blisterverpackten Medikaments
US8439033B2 (en) * 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
WO2009079078A1 (en) 2007-12-14 2009-06-25 Labogroup S.A.S. Delivering aerosolizable food products
ES2546025T3 (es) * 2008-01-24 2015-09-17 Vectura Delivery Devices Limited Inhalador
EP2082764A1 (de) * 2008-01-24 2009-07-29 Boehringer Ingelheim International GmbH Inhalator
EP2100599A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2100598A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2108641A1 (de) 2008-04-11 2009-10-14 Laboratorios Almirall, S.A. Neue substituierte Spiro[Cycloalkyl-1,3'-indo]-2'(1'H)-on-Derivate und ihre Verwendung als p38 mitogen-activated Kinase Inhibitoren
EP2113503A1 (de) 2008-04-28 2009-11-04 Laboratorios Almirall, S.A. Neue substituierte Indolin-2-on- Derivate und ihre Verwendung als p39 mitogen-activated Kinase Inhibitoren
UA99656C2 (en) * 2008-05-23 2012-09-10 Оцука Фармасьютикал Ко., Лтд. Powder inhaler
EP2135610A1 (de) 2008-06-20 2009-12-23 Laboratorios Almirall, S.A. Kombination mit DHODH-Inhibitoren und Methotrexat
EP2177521A1 (de) 2008-10-14 2010-04-21 Almirall, S.A. Neue 2-Amidothiadiazol-Derivate
EP2196465A1 (de) 2008-12-15 2010-06-16 Almirall, S.A. (3-oxo)pyridazin-4-ylurea-Derivate als PDE4 Hemmern
UY32297A (es) 2008-12-22 2010-05-31 Almirall Sa Sal mesilato de 5-(2-{[6-(2,2-difluoro-2-fenilitoxi) hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2( 1h)-ona como agonista del receptor b(beta)2 acrenérgico
EP2202232A1 (de) 2008-12-26 2010-06-30 Laboratorios Almirall, S.A. 1,2,4 Oxadiazolderivate und ihr Einsatz als Arzneimittel
EP2210890A1 (de) 2009-01-19 2010-07-28 Almirall, S.A. Oxadiazol Derivate als S1P1 Rezeptor Agonisten
EP2210615A1 (de) 2009-01-21 2010-07-28 Almirall, S.A. Kombinationen, die Methotrexat und DHODH-Inhibitoren umfassen
EP2221055A1 (de) 2009-02-18 2010-08-25 Almirall, S.A. 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one für die Behandlung von Lungenfunktion
EP2221297A1 (de) 2009-02-18 2010-08-25 Almirall, S.A. 5-(2-{[6-(2,2-Difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxychinolin-2(1H)-on und seine Verwendung bei der Behandlung von Atemwegserkrankungen
EP2226323A1 (de) 2009-02-27 2010-09-08 Almirall, S.A. Neuartige Tetrahydropyrazol[3,4-c]isochinolin-5-amin-Derivate
CA2791847C (en) * 2009-03-04 2017-05-02 Mannkind Corporation An improved dry powder drug delivery system
EP2228368A1 (de) 2009-03-12 2010-09-15 Almirall, S.A. Verfahren zur Herstellung von 5-(2-{[6-(2,2-Difluor-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxychinolin-2(1H)-on
EP2239256A1 (de) 2009-03-13 2010-10-13 Almirall, S.A. Natriumsalz von 5-cyclopropyl-2-{[2-(2,6-difluorphenyl)pyrimidin-5-yl]amino}benzoesäure als DHODH-Inhibitor
EP2305660A1 (de) 2009-09-25 2011-04-06 Almirall, S.A. Neue Thiadiazolderivate
EP2314577A1 (de) 2009-10-16 2011-04-27 Almirall, S.A. Verfahren zur Herstellung von 2-[(3,5-Difluor-3'-methoxy-1,1'-biphenyl-4-yl)amino]nikotinsäure
GB0919465D0 (en) * 2009-11-06 2009-12-23 Norton Healthcare Ltd Airflow adaptor for a breath-actuated dry powder inhaler
EP2322176A1 (de) 2009-11-11 2011-05-18 Almirall, S.A. Neue 7-Phenyl-[1,2,4]triazol[4,3-a]pyridin-3(2H)on-Derivate
EP2498846A4 (de) * 2009-11-13 2014-08-27 Merck Sharp & Dohme Arzneimittelprodukte, trockenpulverinhalatoren und mehrfachfluss-kollisionsanordnungen
EP2343287A1 (de) 2009-12-10 2011-07-13 Almirall, S.A. Neue 2-Aminothiadiazol-Derivate
EP2338888A1 (de) 2009-12-24 2011-06-29 Almirall, S.A. Imidazopyridin-Derivate als JAK-Inhibitoren
EP2360158A1 (de) 2010-02-18 2011-08-24 Almirall, S.A. Pyrazolderivate als JAK-Inhibitoren
UY33213A (es) 2010-02-18 2011-09-30 Almirall Sa Derivados de pirazol como inhibidores de jak
EP2366702A1 (de) 2010-03-18 2011-09-21 Almirall, S.A. Neue Oxadiazolderivate
EP2380890A1 (de) 2010-04-23 2011-10-26 Almirall, S.A. Neue 7,8-Dihydro-1,6-Naphthyridin-5(6H)-on-Derivate als PDE4 Inhibitoren
EP2386555A1 (de) 2010-05-13 2011-11-16 Almirall, S.A. Neue Cyclohexylaminderivate mit Aktivitäten von Beta2-adrenergem Agonisten und M3-Muskarin-Antagonisten
EP2390252A1 (de) 2010-05-19 2011-11-30 Almirall, S.A. Neue Pyrazolderivate
EP2394998A1 (de) 2010-05-31 2011-12-14 Almirall, S.A. 3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl Derivate als PDE4 Inhibitoren
EP2397482A1 (de) 2010-06-15 2011-12-21 Almirall, S.A. Heteroarylimidazolon-Derivate als JAK-Inhibitoren
EP2441755A1 (de) 2010-09-30 2012-04-18 Almirall, S.A. Pyridin- und Isochinolin-Derivate als Syk- und JAK-Kinase-Inhibitors
EP2455081A1 (de) 2010-11-23 2012-05-23 Almirall, S.A. S1P1-Rezeptoragonisten zur Verwendung bei der Behandlung von Morbus Crohn
EP2455080A1 (de) 2010-11-23 2012-05-23 Almirall, S.A. S1P1-Rezeptoragonisten zur Verwendung bei der Behandlung von multipler Sklerose
EP2457900A1 (de) 2010-11-25 2012-05-30 Almirall, S.A. Neue Pyrazolderivate mit CRTH2-antagonistischem Verhalten
EP2463289A1 (de) 2010-11-26 2012-06-13 Almirall, S.A. Imidazo[1,2-b]Pyridazin-Derivate als AS JAK-Hemmer
US8974450B2 (en) 2011-02-03 2015-03-10 Covidien Lp System and method for ablation procedure monitoring using electrodes
EP2489663A1 (de) 2011-02-16 2012-08-22 Almirall, S.A. Verbindungen als Syk-Kinasehemmer
EP2510928A1 (de) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium zur Verbesserung der Schlafqualität bei atemwegserkrankten Patienten
EP2518071A1 (de) 2011-04-29 2012-10-31 Almirall, S.A. Imidazopyridinderivate als PI3K-Inhibitoren
EP2518070A1 (de) 2011-04-29 2012-10-31 Almirall, S.A. Pyrrolotriazinonderivate als PI3K-Inhibitoren
EP2527344A1 (de) 2011-05-25 2012-11-28 Almirall, S.A. Als Medikamente zur Behandlung von myeloproliferativen Krankheiten, Transplantatabstossung, immunbedingten und entzündlichen Erkrankungen geeignete Pyridin-2(1H-)-on-Derivate
EP2526945A1 (de) 2011-05-25 2012-11-28 Almirall, S.A. Neue CRTH2-Antagonisten
EP2548863A1 (de) 2011-07-18 2013-01-23 Almirall, S.A. Neue CRTH2-Antagonisten
EP2548876A1 (de) 2011-07-18 2013-01-23 Almirall, S.A. Neue CRTH2-Antagonisten
EP2554544A1 (de) 2011-08-01 2013-02-06 Almirall, S.A. Pyridin-2(1H-)-on-Derivate als JAK-Inhibitoren
EP2747815B1 (de) 2011-09-07 2017-11-29 Concentrx Pharmaceuticals, Inc. Trockenpulverinhalator
EP2578570A1 (de) 2011-10-07 2013-04-10 Almirall, S.A. Neues Verfahren zur Herstellung von 5-(2-{[6-(2,2-Difluor-2-phenylethoxy)hexyl]amino}-1(R)-hydroxyethyl)-8-hydroxychinolin-2(1H)-on mittels neuen Synthesezwischenstoffen
EP2592078A1 (de) 2011-11-11 2013-05-15 Almirall, S.A. Neue Cyclohexylaminderivate mit Aktivitäten von Beta2-adrenergem Agonisten und M3-Muskarin-Antagonisten
EP2592077A1 (de) 2011-11-11 2013-05-15 Almirall, S.A. Neue Cyclohexylaminderivate mit Aktivitäten von Beta2-adrenergem Agonisten und M3-Muskarin-Antagonisten
EP2617448A1 (de) 2012-01-20 2013-07-24 Almirall S.A. Inhalationsvorrichtung für Arzneimittel in Pulverform
EP2617449A1 (de) 2012-01-20 2013-07-24 Almirall S.A. Inhalationsvorrichtung für Arzneimittel in Pulverform
EP2617450A1 (de) 2012-01-20 2013-07-24 Almirall S.A. Inhalationsvorrichtung für Arzneimittel in Pulverform
EP2641900A1 (de) 2012-03-20 2013-09-25 Almirall, S.A. Neuartige polymorphe Kristallformen von 5-(2-{[6-(2,2-difluor-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxychinolin-2(1H)-on, Heminapadisylat als Agonist des beta2-adrenergen Rezeptors
EP2647627A1 (de) 2012-04-02 2013-10-09 Almirall, S.A. Salze von 5-[(1r)-(2-{[4-(2,2-difluor-2-phenylethoxy)phenyl].ethyl}amino}-1- hydroxyethyl)-8-hydroxychinolin-2(1H)-on.
EP2666465A1 (de) 2012-05-25 2013-11-27 Almirall, S.A. Neuartige Dosierung und Formulierung
EP2668941A1 (de) 2012-05-31 2013-12-04 Almirall, S.A. Neue Darreichungsform und Formulierung von Abediterol
WO2014060431A1 (en) 2012-10-16 2014-04-24 Almirall, S.A. Pyrrolotriazinone derivatives as pi3k inhibitors
EP2738172A1 (de) 2012-11-28 2014-06-04 Almirall, S.A. Neue bizyklische Verbindungen als CRAC-Kanalmodulatoren
WO2014095663A1 (en) 2012-12-17 2014-06-26 Almirall, S.A. New use of aclidinium
MA38260B1 (fr) 2012-12-18 2018-04-30 Almirall Sa Nouveaux dérivés de cyclohexyl et quinuclidinyl carbamate ayant une activité d'agoniste adrénergique beta2 et une activité d'antagoniste muscarinique m3
UY35332A (es) 2013-02-15 2014-11-28 Almirall Sa Derivados de pirrolotriazina como inhibidores de pi3k
EP2848615A1 (de) 2013-07-03 2015-03-18 Almirall, S.A. Neue Pyrazolderivate als CRAC-Kanalmodulatoren
WO2015091287A1 (en) 2013-12-19 2015-06-25 Almirall S.A. Dosage formulation comprising salmeterol and fluticasone propionate
EP2944343A1 (de) 2014-05-15 2015-11-18 AstraZeneca AB Trockenpulverinhalator
PT3151893T (pt) * 2014-06-06 2018-05-18 Univ Groningen Um inalador de pó seco acionado por respiração
ES2701202T3 (es) * 2014-11-26 2019-02-21 Vectura Delivery Devices Ltd Dispositivo de apertura de envases tipo blíster para inhalador de polvo seco
JP2018501903A (ja) 2015-01-14 2018-01-25 レスピラ セラピューティクス インコーポレイテッドＲｅｓｐｉｒａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． パウダー分散方法および装置
MA41938A (fr) 2015-04-21 2018-02-28 Almirall Sa Dérivés hétérocycliques amino-substitués utilisés comme inhibiteurs des canaux sodiques
WO2016202800A1 (en) 2015-06-16 2016-12-22 Almirall, S.A. Pyrrolotriazinone derivatives as pi3k inhibitors
WO2017076990A1 (en) 2015-11-05 2017-05-11 Almirall, S.A. Addition salts of n-[4-(4-{[(1s)-1-(5-methyl-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-2-yl)ethyl]amino}-7h-pyrrolo[2,3-d]pyrimidin-5-yl)-1h-indol-6-yl]sulfamide
RU2634258C1 (ru) * 2016-11-08 2017-10-24 федеральное государственное автономное образовательное учреждение высшего образования "Российский университет дружбы народов" (РУДН) Наполнитель для капсульного ингалятора
AU2017369978A1 (en) * 2016-11-30 2019-04-11 Philip Morris Products S.A. Inhaler with sized cavity
CN110494181B (zh) 2017-03-28 2022-03-18 康森特里克斯药物公司 用于输送干粉药物的装置和方法
CN107123354B (zh) * 2017-05-21 2019-03-19 谭淞文 分选花形微粒载体的吸入器、呼吸道及肺部模型设备集成
TW201919682A (zh) 2017-08-08 2019-06-01 西班牙商阿爾米雷爾有限公司 活化Ｎｒｆ２路徑的新穎化合物
CN111526747B (zh) * 2018-02-19 2023-11-07 菲利普莫里斯生产公司 干粉吸入器
CN110201278B (zh) * 2018-02-28 2021-07-30 张江 用于吸入给药的药盒和吸入给药组合结构
CN110201281B (zh) * 2018-02-28 2021-08-06 张江 吸入给药装置和吸入给药组合结构
CN110201279B (zh) * 2018-02-28 2021-05-11 张江 用于吸入给药的药盒和吸入给药组合结构
CN110201280B (zh) * 2018-02-28 2021-07-30 张江 用于吸入给药装置的吸嘴和吸入给药装置
CN111514418B (zh) * 2019-06-12 2022-01-14 中南大学湘雅二医院 一种自吸式经鼻粉末材料给送装置
CN111359060A (zh) * 2020-02-20 2020-07-03 深圳麦克韦尔科技有限公司 雾化吸嘴及雾化装置
CN113750331B (zh) * 2021-08-18 2022-08-16 华中科技大学 一种干粉吸入器
CN114632235B (zh) * 2022-03-04 2023-04-25 华中科技大学 一种干粉吸入器
CN115006656A (zh) * 2022-05-18 2022-09-06 苏州易合医药有限公司 一种可连续提供肺部活性剂粉雾剂的给药装置

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1478138A (en) * 1973-07-18 1977-06-29 Beecham Group Ltd Device for the administration of powders
IT7920688V0 (it) 1979-02-05 1979-02-05 Chiesi Paolo Parma Inalatore per sostanze medicamentose pulverulente, con combinata funzione di dosatore.
DE3274065D1 (de) 1981-07-08 1986-12-11 Draco Ab Powder inhalator
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
DE3927170A1 (de) 1989-08-17 1991-02-21 Boehringer Ingelheim Kg Inhalator
IT1237118B (it) 1989-10-27 1993-05-18 Miat Spa Inalatore multidose per farmaci in polvere.
WO1992003175A1 (en) 1990-08-11 1992-03-05 Fisons Plc Inhalation device
DE4211475A1 (de) * 1991-12-14 1993-06-17 Asta Medica Ag Pulverinhalator
DE4239402A1 (de) * 1992-11-24 1994-05-26 Bayer Ag Pulverinhalator
ATE177323T1 (de) 1992-12-18 1999-03-15 Schering Corp Inhalator für pulverförmige medikamente
ES2152427T3 (es) * 1994-10-04 2001-02-01 Procter & Gamble Pulverizacion electrostatica de material particulado.
DE19522416C2 (de) * 1995-06-21 2003-11-20 Sofotec Gmbh & Co Kg Vorrichtung zum Dispergieren von Pulver in einem Luftstrom zur Verwendung mit Pulver-Inhalatoren
NZ502870A (en) * 1995-06-21 2001-06-29 Asta Medica Ag Inhaler for powdered medicaments comprising a visual display device to indicate the discharge status of the inhaler
FR2738153B1 (fr) * 1995-09-04 1998-01-02 Valois Appareil d'inhalation destine a distribuer des doses precises et reproductibles de produit pulverulent
EP1129705A1 (de) * 2000-02-17 2001-09-05 Rijksuniversiteit te Groningen Pulverformulierung zur Inhalation

Also Published As

Publication number Publication date
AU2009200071A1 (en) 2009-02-05
HRP20040058B1 (hr) 2015-02-27
SI1397174T1 (sl) 2010-12-31
NO20035654L (no) 2004-02-18
AU2009200071B2 (en) 2011-07-07
PT1397174E (pt) 2010-11-10
SK272004A3 (sk) 2005-10-06
KR20040039203A (ko) 2004-05-10
CN100337699C (zh) 2007-09-19
NZ530308A (en) 2007-01-26
CZ200446A3 (cs) 2005-02-16
HK1064313A1 (en) 2005-01-28
HRP20040058A2 (en) 2004-08-31
BR0210026A (pt) 2004-04-13
DE60237366D1 (de) 2010-09-30
EP1397174B1 (de) 2010-08-18
RU2004102037A (ru) 2005-05-27
IL210983A0 (en) 2011-04-28
KR100904955B1 (ko) 2009-06-26
MXPA03011550A (es) 2004-03-18
NO20035654D0 (no) 2003-12-17
NO332992B1 (no) 2013-02-11
HUP0400212A2 (en) 2004-06-28
IL158614A0 (en) 2004-05-12
SK288034B6 (en) 2013-01-02
BG108512A (en) 2005-02-28
IL158614A (en) 2012-12-31
BRPI0210026B8 (pt) 2021-06-22
HU227457B1 (en) 2011-06-28
AR034616A1 (es) 2004-03-03
BG66589B1 (bg) 2017-07-31
JP4116537B2 (ja) 2008-07-09
DK1397174T3 (da) 2010-12-06
ES2350973T3 (es) 2011-01-28
PL365946A1 (en) 2005-01-24
CA2445892A1 (en) 2003-01-03
UA74648C2 (en) 2006-01-16
ZA200308555B (en) 2004-02-17
RU2291717C2 (ru) 2007-01-20
PL204900B1 (pl) 2010-02-26
JP2004530498A (ja) 2004-10-07
CN1541125A (zh) 2004-10-27
CA2445892C (en) 2010-08-10
TW567075B (en) 2003-12-21
CY1110924T1 (el) 2015-06-10
WO2003000325A1 (en) 2003-01-03
BRPI0210026B1 (pt) 2018-04-03
EP1397174A1 (de) 2004-03-17
CZ302528B6 (cs) 2011-07-07
DE10129703A1 (de) 2003-01-02
IL210983A (en) 2014-11-30

Similar Documents

Publication Publication Date Title
ATE477826T1 (de) Pulverformulierungs-disintegrationssystem und trockenpulverinhalatoren
HUP0300593A3 (en) Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
EP1487417A4 (de) Medikamentöse trockenpulver-formulierungen
DE60035911D1 (de) Trockenpulverinhalator
ATE460955T1 (de) Trockenpulver-inhalator
EP1364957A4 (de) Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
EP1364958A4 (de) Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
TWI319319B (en) New solid pharmaceutical formulations comprising telmisartan and preparation thereof
HUP0400384A3 (en) Benzamidine derivative and pharmaceutical compositions containing them and their use
HK1164133A1 (en) Nasal pharmaceutical formulations and methods of using the same
DE69915144D1 (de) Aerosoldruckdosiergeräte und Aerosolarzneizusammensetzungen
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
HK1091727A1 (en) Nasal pharmaceutical formulations and methods of using the same
DE60131760D1 (de) Vorrichtung zur verabreichung von physiologisch aktiven wirkstoffen in pulverform
ATE383868T1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
GB0108470D0 (en) Pharmaceutical compositions and their use
DE50213084D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
HK1069385A1 (en) Heterocyclic compound and medicinal use thereof
HUP0402318A3 (en) Pharmaceutical composition comprising cyclosporin and use thereof
NO20022022L (no) N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
PL367676A1 (en) Novel heterocyclic derivatives and medicinal use thereof
GB0003935D0 (en) Formulation for dry powder inhaler
DE60024476D1 (de) Pedikulizide und veterinärmedizinische zusammensetzungen
IL160886A0 (en) Nicotine containing pharmaceutical formulations and use thereof
NO20004816D0 (no) Ny farmasøytisk formulering

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1397174

Country of ref document: EP